Health roundupFriday 23 October 2026

mRNA vaccine slashes melanoma return risk

The biggest news today is a real win for mRNA technology outside of COVID: a personalized cancer vaccine cut melanoma recurrence by 42% in a late-stage trial. Meanwhile, a Microsoft AI tool doubled the diagnostic accuracy of general physicians, and a handful of other stories quietly moved the needle on kidney biopsies and cannabis risks.

In today's edition: Treatment breakthroughs and Risks and protocols, plus quick bites.

Treatment breakthroughs

Two pieces of research landed today that could change how we treat cancer and diagnose disease.

Risks and protocols

Two studies this week add nuance to how we think about common drugs and procedures.

Quick bites